(Q33633172)

28 July 2017

Specific inhibitors of the breast cancer resistance protein (BCRP). (English)

1 reference

28 July 2017

Anne Pick

1

1 reference

PubMed ID

20632361

28 July 2017

Werner Klinkhammer

series ordinal

2

1 reference

PubMed ID

20632361

28 July 2017

Michael Wiese

series ordinal

3

1 reference

28 July 2017

1 September 2010

1 reference

28 July 2017

1 reference

28 July 2017

5

1 reference

28 July 2017

9

1 reference

28 July 2017

1498-1505

1 reference

The role of multidrug transporters in drug availability, metabolism and toxicity

28 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

A family of drug transporters: the multidrug resistance-associated proteins.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

ABCG2 -- a transporter for all seasons

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

A multidrug resistance transporter from human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

ABCG2 transports sulfated conjugates of steroids and xenobiotics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Bryostatin-I: an antineoplastic treasure from the deep?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Interaction of the breast cancer resistance protein with plant polyphenols

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

A new strategy of high-speed screening and quantitative structure-activity relationship analysis to evaluate human ATP-binding cassette transporter ABCG2-drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

New functional assay of P-glycoprotein activity using Hoechst 33342.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Novel modulators to overcome P-glycoprotein-mediated multidrug resistance in tumor cells.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000216

7 January 2021

Identifiers

DOI

10.1002/CMDC.201000216

1 reference

28 July 2017

1 reference

PubMed ID

20632361